HomeSPH • WSE
add
Sopharma AD
Previous close
zł 13.40
Day range
zł 12.65 - zł 13.10
Year range
zł 11.40 - zł 14.40
Avg Volume
81.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (BGN) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 587.96M | 16.63% |
Operating expense | 116.72M | 18.70% |
Net income | 13.40M | -26.51% |
Net profit margin | 2.28 | -37.02% |
Earnings per share | — | — |
EBITDA | 15.32M | -32.52% |
Effective tax rate | 13.91% | — |
Balance Sheet
Total assets
Total liabilities
| (BGN) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 36.07M | -72.01% |
Total assets | 1.80B | 18.89% |
Total liabilities | 950.83M | 25.02% |
Total equity | 849.36M | — |
Shares outstanding | 165.74M | — |
Price to book | 2.70 | — |
Return on assets | 0.92% | — |
Return on capital | 1.20% | — |
Cash Flow
Net change in cash
| (BGN) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 13.40M | -26.51% |
Cash from operations | 54.29M | -53.06% |
Cash from investing | -100.69M | -506.29% |
Cash from financing | 44.28M | 256.94% |
Net change in cash | -2.13M | -101.91% |
Free cash flow | 41.44M | -75.01% |
About
Founded
1933
Website
Employees
5,599
